Skip to main content
Equibles

Creative Planning

Position in CRDF — Cardiff Oncology, Inc.

CIK 1540235 OVERLAND PARK, KS
Back to CRDF Full portfolio

Position in CRDF

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$62,526
-$8,122 QoQ
Shares Held
48,097
+10.3% QoQ
Ownership
0.062%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#35
of 104 holders
Holding Since
Sep 2022
16 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in CRDF Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Creative Planning holds $457,365,908 across 219 Biotechnology names. CRDF ranks #195 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 127,672 $63,418,511
2 REGN
Regeneron Pharmaceuticals, Inc.
 36,949 $23,039,178
3 EXEL
Exelixis, Inc.
 270,292 $14,706,586
4 INCY
Incyte Corp
 110,664 $12,544,870
5 CYTK
Cytokinetics Inc
 141,939 $12,091,783
6 RVMD
Revolution Medicines, Inc.
 64,120 $12,008,393
7 ARGX
Argenx SE
 12,744 $11,823,500
8 BMRN
Biomarin Pharmaceutical Inc
 153,161 $8,763,872

All Filings in CRDF

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $62,526 48,097
2026-03-31 $70,648 43,610
2025-12-31 $105,245 37,454
2025-09-30 $82,610 40,102
2025-06-30 $107,257 34,050
2025-03-31 $208,401 66,370
2024-12-31 $264,601 60,968
2024-09-30 $143,029 53,569
2024-06-30 $121,511 54,735
2024-03-31 $214,940 40,251
2023-12-31 $37,740 25,500
2023-09-30 $81,663 58,751
2023-06-30 $84,892 57,750
2023-03-31 $40,425 24,500
2022-12-31 $34,300 24,500
2022-09-30 $39,385 25,575